Pleuroparenchymal Fibroelastosis as Another Potential Lung Toxicity Pattern Induced by Amiodarone

Oliveira, Marcos; Melo, Natália; Caetano Mota, Patrícia; Novais e Bastos, Helder; Pereira, José Miguel; Carvalho, André; Guimarães, Susana; Moura, Conceição Souto; Morais, António.
Arch. bronconeumol. (Ed. impr.) ; 56(1): 55-56, ene. 2020. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-186473

Documentos relacionados

  1. Suppressing NLRP3 activation and PI3K/AKT/mTOR signaling ameliorates amiodarone-induced pulmonary fibrosis in rats: a possible protective role of nobiletin.
  2. Analysis of Live Single Cells by Confocal Microscopy and High-Resolution Mass Spectrometry to Study Drug Uptake, Metabolism, and Drug-Induced Phospholipidosis.
  3. [The pulmonary toxicity of amiodarone: six-case report].
  4. [Amiodarone-induced pulmonary fibrosis].
  5. Pleuroparenchymal Fibroelastosis as Another Potential Lung Toxicity Pattern Induced by Amiodarone.
  6. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature.
  7. Gallium-67 and pulmonary complications of amiodarone.
  8. Pulmonary gallium-67 uptake in amiodarone pneumonitis.
  9. [Lung abnormalities in interstitium and alveoli following treatment with amiodarone].
  10. Assessment Of Ratio Of Peak Expiratory Flow Rate To Vital Capacity For Identifying Pulmonary Fibrosis.